Aktie A043090 THE TECHNOLOGY CO.,LTD.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen The Technology Co.,Ltd.

Aktien

A043090

KR7043090000

A043090

Schlusskurs Korea S.E.
Andere Börsenplätze
 00:00:00 10.05.2024 		% 5 Tage % 1. Jan.
425 KRW 0.00% Intraday Chart für The Technology Co.,Ltd. -3.85% -33.59%
2023 Exergy21 Co., Ltd. meldet Ergebnis für das am 31. Dezember 2022 endende Geschäftsjahr CI
2021 Hanchang Biotech Co. Ltd. (KOSDAQ:A043090) erwarb für 2,7 Mrd. KRW einen Anteil von 5,61 % an der Hanju Chemical Company Ltd. CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
PangSky Corp. announced that it has received KRW 1 billion in funding from Exergy21 Co., Ltd.
PangSky Corp. announced that it expects to receive KRW 1 billion in funding from Exergy21 Co., Ltd.
Exergy21 Co., Ltd. announced that it expects to receive KRW 24.999999475 billion in funding
Kattus Co., Ltd. announced that it has received KRW 5.999 billion in funding from Exergy21 Co., Ltd.
Kattus Co., Ltd. announced that it expects to receive KRW 5.999 billion in funding from Exergy21 Co., Ltd.
Exergy21 Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
Exergy21 Co., Ltd. announced that it expects to receive KRW 25 billion in funding
Hanchang Biotech Co., Ltd. announced that it has received KRW 15 billion in funding from Exergy21.Inc
HanChang Biotech to Raise $9.2 Million Through Stock Offering
Hanchang Corporation entered into an agreement to acquire 73.98% for KRW 25 billion.
Exergy21 Co., Ltd. announced that it expects to receive KRW 79.99999938 billion in funding from Jeonheung CNC Co., Ltd.
Hanchang Biotech Co., Ltd. announced that it expects to receive KRW 12.5 billion in funding from Jeonheung CNC Co., Ltd.
Hanchang Biotech Co., Ltd. announced that it expects to receive KRW 15 billion in funding from Exergy21.Inc
An undisclosed buyer agreed to acquire 8.6% stake in Hanchang Biotech Co., Ltd. from Hanchang Corporation for KRW 6.8 billion.
Hanchang Biotech Co., Ltd. announced that it expects to receive KRW 27.49999938 billion in funding
Hanchang Biotech Co., Ltd. announced that it expects to receive KRW 11.99999925 billion in funding from Jeonheung CNC Co., Ltd.
Hanchang Biotech Co., Ltd. announced that it expects to receive KRW 12.49999938 billion in funding from Jeonheung CNC Co., Ltd.
Hanchang Biotech Co., Ltd. acquired 5.61% stake in Hanju Chemical Company Ltd for KRW 2.7 billion.
Hanju Chemical & Holdings Co., Ltd. announced that it has received KRW 12.49999978 billion in funding from Hanchang Corporation, Jaanh Holdings Co., Ltd., CHOROKBAEM COMPANY Co., Ltd.
Hanju Chemical & Holdings Co., Ltd. announced that it has received KRW 8 billion in funding from Jiyuon Co., Ltd.
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A043090 Aktie
  4. Nachrichten The Technology Co.,Ltd.
  5. Andere Sprachen